James B. Breitmeyer, EVP, CMO at CADENCE PHARMACEUTICALS INC (CADX), sold 25,000 shares at $9.00 ($226K) on 2010-11-01, disclosed to the SEC on 2010-11-03.
Scheduled sale ($226k) by EVP, CMO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.00 | 7,000 | $63K | 27.9% |
| 2 | $9.05 | 18,000 | $163K | 72.1% |
| Total | $9.04 avg | 25,000 | $226K | 100% |
| Filing → |
| ZGNX | SELL | 2019-12-18 | $250K | — | Filing → |
| ZGNX | SELL | 2019-11-27 | $250K | — | Filing → |
| CADX | SELL | 2011-11-04 | $71K | — | Filing → |